Biotech investors have been here before.
Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%.
And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell off we saw in the sector […]
Over the course of this long bull market, biotech stocks have been very, very good for their owners. Perhaps too good. Investors have shown such rabid enthusiasm for biotechs—especially small, unproven companies that have yet to bring a drug to market—that some observers are using another b word to describe the high-flying sector: bubble.See Also: 8 Stocks Under $10 Worth […]
View gallery.(Flickr/Gonzalo Iza)Biotech investors have been here before.
Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell off we saw in […]
Myles Udland
Mar. 25, 2015, 2:55 PM
2,690
Flickr/Gonzalo IzaBiotech investors have been here before.Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell […]
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
I’m baaaack…Yep – back in the saddle after roughing it in the desert for a week. I fended off mountain lion attacks…lost a few bucks betting on March Madness during a detour to Vegas…and meditated on the markets while staring up at the stars.Stocks stabilized in my absence after wandering lower during that pesky early-March pullback. The major averages aren’t […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks are selling off on Thursday after a post-Fed rally yesterday.
But biotech stocks are rallying, up nearly 2%. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last week, Max Nisen at Quartz wrote that while everyone is focusing on massive tech valuations, the biotech industry is where things […]
NEW YORK (MarketWatch) — The current bull market is marking its sixth birthday, and a few slices of the stock market have more reason to celebrate than others.Who really deserves to whoop it up? Biotech and pharma ETFs, value ETFs that aim to find bargains, and ETFs targeting consumer-discretionary or retail stocks.The 10 ETFs that have performed best since the […]
By Ben LevisohnBiotech stocks like Gilead Sciences (GILD) and Amgen (AMGN) have been a great place to be for investors. Now, the approval of the first biosimilar in the U.S. is raising concerns that biotech profits will decline–and causing their stocks to tumble. Citigroup’s Andrew Baum and team explain why:
Bloomberg News
Approval of Sandoz’s Zarxio, with full extrapolation across indications and lack […]
